Capital Fund Management S.A. Teva Pharmaceutical Industries LTD Call Options Transaction History

Capital Fund Management S.A.

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $1.01 Million - $1.38 Million	-79,100 Reduced 58.08%	57,100 $927,000
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $975,238 - $1.32 Million	91,400 Added 204.02%	136,200 $1.92 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $363,775 - $476,224	44,800 New	44,800 $467,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $3 Million - $4.9 Million	-205,400 Reduced 9.61%	1,932,100 $29.8 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $3.18 Million - $3.88 Million	151,200 Added 7.61%	2,137,500 $46 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $256,581 - $378,063	-15,300 Reduced 0.76%	1,986,300 $48.3 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $29.1 Million - $38.5 Million	-1,742,400 Reduced 46.54%	2,001,600 $34.2 Million
Q4 2017 Feb 09, 2018	BUY	$11.23 - $19.1 $13.1 Million - $22.3 Million	1,169,400 Added 45.42%	3,744,000 $70.9 Million
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $39.7 Million - $82.8 Million	2,574,600	2,574,600 $45.3 Million

603

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.